Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-18-000027
Filing Date
2018-01-02
Accepted
2018-01-02 18:15:40
Documents
1
Period of Report
2017-12-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_5173.html 4  
1 PRIMARY DOCUMENT doc4_5173.xml 4 7599
  Complete submission text file 0001638599-18-000027.txt   9030
Mailing Address 50 AVENUE GENERAL DE GAULLE BRUXELLES C9 9999999999
Business Address
HILL STEPHEN A (Reporting) CIK: 0001237404 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36357 | Film No.: 18502939

Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Issuer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations